Health Select Committee Reports Back on Avastin Petition
In November 2019 Brain Tumour Support NZ presented a petition to Parliament on behalf of Sel Leigh and the Tahu Hikuroa Foundation calling for the government to publicly fund bevacizumab (Avastin) for relapsed or refractory high-grade gliomas. The Health Select Committee has now published their report on the petition. Read about what they had to say and find out how you can help advocate for better treatments.